Flexion Therapeutics Claimed Company
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. read more
Christina Willwerth — Chief Strategy Officer at Flexion Therapeutics
Executive Bio
Ms. Willwerth has more than 25 years of experience in pharmaceutical development. Most recently, Ms. Willwerth served as Flexion’s Senior Vice President of Program Management and Strategy, and in her expanded role she continues to lead the planning and execution of our strategic vision and business priorities and have accountability for Flexion’s portfolio development efforts and Human Resources activities. Ms. Willwerth joined Flexion Therapeutics from Viacell, where she was a member of the company’s Executive Management team and served as Vice President, Product Development, with management responsibility for the company’s interdisciplinary cellular therapy and fertility preservation development programs. She previously served as Senior Director, Product Development at The Medicines Company, where she focused on cardiovascular therapy clinical and product development.
Executive Team Culture Ratings from Flexion Therapeutics Employees
TOP
5%
Flexion Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Flexion Therapeutics' Executive Team at a Glance
Based on 105 ratings, Flexion Therapeutics' employees are very satisfied with their Executive Team and give them an “A+” or 95/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the IT department thinks more highly of the Executive Team relative to the HR department.
Flexion Therapeutics' Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 201-500 Employees.
×